Bluetters-Sawatzki R, Friedrich W, Ebell W, Vetter U, Stoess H, Goldmann S F, Kleihauer E
Kinderklinik, Ulm, Federal Republic of Germany.
Eur J Pediatr. 1989 Nov;149(2):104-9. doi: 10.1007/BF01995857.
Three infants with severe combined immunodeficiency and adenosine deaminase (ADA) deficiency were treated by T-cell depleted bone marrow transplantation (BMT), using human leukocyte antigen (HLA)-haploidentical parents as donors. In the first patient, two initial transplants failed to engraft and no change of the immunodeficiency was observed. In order to overcome this graft resistance, cytoreductive conditioning was used prior to a third transplant. In the other two patients, similar conditioning was used prior to initial transplants. In all three patients, complete and permanent immunological reconstitution was observed and they survive from 3.5 to 5 years after transplantation. In biopsies obtained from iliac bones prior to BMT, osteochondral abnormalities characteristic of ADA-deficiency were noted in all three patients. After successful transplantation, these abnormalities had completely resolved. Our results demonstrate that cytoreductive conditioning prior to HLA-haploidentical BMT is useful in order to obtain stable engraftment and reversal of abnormalities associated with ADA deficiency.
三名患有严重联合免疫缺陷和腺苷脱氨酶(ADA)缺乏症的婴儿接受了以人类白细胞抗原(HLA)单倍型相合的父母为供体的去除T细胞的骨髓移植(BMT)治疗。在第一名患者中,最初的两次移植未能植入,免疫缺陷也未观察到变化。为了克服这种移植物抗性,在第三次移植前采用了细胞减灭预处理。在另外两名患者中,在初次移植前采用了类似的预处理。在所有三名患者中,均观察到完全且持久的免疫重建,并且他们在移植后存活了3.5至5年。在BMT前从髂骨获取的活检组织中,所有三名患者均发现了ADA缺乏症特有的骨软骨异常。成功移植后,这些异常已完全消失。我们的结果表明,在HLA单倍型相合的BMT前进行细胞减灭预处理有助于获得稳定的植入并逆转与ADA缺乏相关的异常。